What this determination covers
The Health Insurance (Section 4BA - Pathologist-Determinable Services) Amendment (Ribonucleic Acid Testing for Hepatitis C) Determination 2026 is a technical rule change made on 7 April 2026 under the Health Insurance Act 1973. It amended the rules covering pathologist-determinable services to add RNA (Ribonucleic Acid) testing for Hepatitis C.
Period in force
The determination was in force from 7 April 2026 to 18 August 2026. After 18 August 2026 it was repealed, meaning its amendments were absorbed into the parent instrument: the Health Insurance (Section 4BA - Pathologist-Determinable Services) Determination 2025.
What was not specified
The source document does not specify what changes were made to individual Medicare item numbers or fee amounts.
Administering department
This determination is administered by the Department of Health, Disability and Ageing.
Key actions
- Pathology providers billing RNA testing for Hepatitis C under Medicare are required to check the current Health Insurance (Section 4BA - Pathologist-Determinable Services) Determination 2025 on the Federal Register of Legislation at legislation.gov.au to confirm the current approved item rules.
- To obtain a print copy of this instrument, the Federal Register of Legislation provides an Order print copy function at https://www.legislation.gov.au/F2026L00413.
- Alerts for future changes to the parent instrument can be set up using the Set up an alert function on the relevant title page at legislation.gov.au.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.